Drugs / DT3aP-HBs-IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00355654 Comparator | Sep 2006 → Sep 2007 | — | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DT3aP-HBs-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00355654 ↗ |
| Modality | Vaccine | “Booster Vaccination With Infanrix® Hexa” NCT00355654 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00355654 ↗ |